1.
Wichrowska M, Kocięcki J, Suda W. Switching between aflibercept and ranibizumab in the treatment of refractory exudative age-related macular degeneration. Ophthatherapy [Internet]. 2021Aug.27 [cited 2024Apr.19];8(3):167-73. Available from: https://journalsmededu.pl/index.php/ophthatherapy/article/view/1329